Erlotinib lactam impurity
Erlotinib lactam impurity (compound 7a) is a precursor of the tyrosine kinase inhibitor[1].
Product Specifications
CAS Number
179688-29-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Intermediate
Related Pathways
Others
Field of Research
Cancer
Purity
98.50
Smiles
O=C1NC=NC2=C1C=C(C(OCCOC)=C2)OCCOC
Molecular Formula
C14H18N2O5
Molecular Weight
294.30
Precautions
H302, H315, H319, H335
References & Citations
[1]Yann Seimbille, et al. Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of 18F-Iressa and related molecular probes. J Label Compd Radiopharm 2005; 48: 829–843.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402383-100 1x 100 µL
CD40 / TNFRSF5 / CD40L-Receptor (C40/2383), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details